Your trusted source for investing success

Tag: medical research

Looking for Cannabis Stocks?


Read our report to find market data, important news and stocks to watch!


PUF Ventures Inc. – Australia to Allow Exportation of Cannabis Products

PUF Ventures Inc. – Australia to Allow Exportation of Cannabis Products

PUF Ventures Inc. (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF), an advanced Access to Cannabis for Medical Purposes Regulations (“ACMPR”) license applicant, is pleased to announce the Australian government intends to expunge the export ban on cannabis products in February 2018 and allow the export of cannabis products worldwide. The Australian

Australia to Allow Exportation of Cannabis Products

Australia to Allow Exportation of Cannabis Products

MYM Nutraceuticals Inc. (CSE: MYM) (“MYM”) is excited to announce that Australia will expunge the export ban on cannabis products in February 2018 and allow the worldwide exportation of cannabis-based treatments such as oils, patches, sprays, lozenges and tablets. The Australian Federal Government has big ambitions for Australia to become

Cannabis Big News Roundup

Cannabis Big News Roundup

Dec. 22 Big News Roundup: Phivida Completes IPO, DOJA and Tokyo Smoke Announce Merger, INDIVA Signs Supply Agreement
In case you missed it, here is this week’s cannabis big news roundup:

Phivida Holdings Inc. Completes Initial Public Offering
Valens GroWorks Receives Processing License
Maple Leaf Commences Foundation Construction for its Telkwa, British Columbia

Phivida Launches CBD Products into USA Clinical Markets

Phivida Launches CBD Products into USA Clinical Markets

Phivida Holdings Inc. (CSE:VIDA) is pleased to report the official launch of its clinical grade cannabidiol products into the USA clinical market under the brand name Vida+. The launch of Vida+ CBD is coincided with a national clinical education campaign focused on providing the US alternative healthcare community with validated data on

MYM Australia Project Announces Application Acceptance and Name Change

MYM Australia Project Announces Application Acceptance and Name Change

MYM Nutraceuticals Inc., (CSE: MYM) (CSE: MYM.CN) (OTC: MYMMF) (the “Company” or “MYM”) is pleased to announce that applications for a medicinal cannabis license for the Northern Rivers Project in Australia, for both cultivation and production, cannabis research license and manufacturing license have been accepted by the Office of Drug

Canadian Marijuana Stocks

Canadian Marijuana Stocks

The Canadian marijuana sector is one of the hottest growing sectors. Here’s a look at Canadian cannabis companies for investors to consider.

Looking for Cannabis Stocks?


Read our report to find market data, important news and stocks to watch!


Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
Exclusive: High Hampton CEO Talks Challenges for the California Market

URL: https://investingnews.com/daily/resource-investing/agriculture-investing/cannabis-investing/exclusive-high-hampton-ceo-talks-challenges-california-market/